Back to playlist
Commented videos
Video : Interventional treatment of venous thrombosis
Video : Interventional treatment of venous thrombosis
Comments : Video : Interventional treatment of venous thrombosis
Comments : Video : Interventional treatment of venous thrombosis
Sharif Khashaba K. kindly improve the voice
Vanessa R. How do you treat venous non thrombotic in stent restenosis
Gustavo R. In chronic oclusion how often did you see instent stenosis in Iliocaval Wallstent
Olivier H. in our experience on 162 patients with a median follow-up of 44 months, primary patency is 70% at 60 months and assisted primary patency 85%
Peter N. Using the Wallstent, the cumulative in-stent stenosis rate at 6 years is in non-thrombotic obstructions (NIVL) 1% and in postthrombotic obstructions approximately 10%. In-stent stenosis is then defined as being >50% lumen reduction. It is common to see some in-stent layering of
Jacobo N. What do you think is the best aproach to the lesion, popliteal or contralateral? Thanks
Olivier H. for chronic lesion, i prefer anterograde approach through the femoral or popliteal. Some teams favor internal jugular approach (must always be ready in case of IVC lesions)
for acute lesions, it depends on the patency of the popliteal vein. If occluded, jugular or controlateral acess
Maria Fabrizia G. do you use the same strategy in presence of PE?
Olivier H. PE does not change the strategy but can make discuss the use of an IVC filter
bander A. what is he indications in case of non thrombotic iliac vein lesion ?
Olivier H. symptomatic and disabled patients C2-6, pelvic congestion syndrome
Peter N. I agree with Olivier, but wants to qualify it slightly. As we pointed out in the discussion, compression of the iliac veins are common in the asymptomatic population and possibly up to 30% have >50% stenosis with no symptoms! So there is a potential risk of overtreatment. In chronic venous disease of the lower limb, treatment of the outflow obstruction is indicated in patients with the C-class in CEAP being marked swelling (C3) and those with skin changes/ulcers (C4-C6). In addition, you have those patients with venous pain without skin changes or varicose veins, which can not be solely explained by the presence of reflux, if any. We use visual analogue scale (VAS) to evaluate that, considering VAS >5 being significant. As Olivier pointed out the symptoms have to affect the patients' quality of life.
Sandeep S. When using three stents, why is the middle stent placed last in iliofemoral venous intervention?
Is there any algorithim to decide on when and not to stent across deep femoral vein?